Utah Medical Products to build blood monitoring facility in Ireland:
This article was originally published in Clinica
Executive Summary
Utah Medical Products is to construct a manufacturing facility in Athlone, Ireland. Initial capital of $4 million will come from the company's current cash supplies and production will begin in Athlone in early 1996. The new facility will house assembly operations for blood monitoring components and Utah's electrosurgery product line. This will eliminate the need for European third-party local repair and warranty service, says Utah. Moreover, the company's largest non-Baxter OEM customer has agreed to hand over its EU customer base for blood pressure monitoring kits to Utah, once the facility is complete.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.